Clinical Trial Update: An Imaging Study of Anti-GD2-800CW in Patients With Neuroblastoma [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial is evaluating the imaging agent Anti-GD2-800CW in patients with neuroblastoma. The study is in Phase 1/2 and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Anti-GD2-800CW

Snippet

Sponsor: Princess Maxima Center for Pediatric Oncology | Conditions: Neuroblastoma | Phase 1, Phase 2 | Status: RECRUITING